The Science
GLP-1 (glucagon-like peptide-1) receptor agonists — originally developed for metabolic health — are showing remarkable promise in the treatment of alcohol use disorder. Research suggests that GLP-1 receptors are present in the brain's reward circuitry, particularly in areas governing craving and impulse control. When activated, these receptors appear to dampen the dopamine-driven reward response that makes alcohol feel pleasurable and reinforcing — effectively quieting the neurological "pull" toward drinking.
At low doses, GLP-1 agonists have been observed to reduce alcohol cravings, lower the frequency and volume of drinking and in some individuals produce a natural disinterest in alcohol altogether. Preclinical studies and emerging clinical data indicate that this effect may be dose-dependent, meaning therapeutic benefit can be achieved without the side effects typically associated with higher doses used in metabolic treatment.
Unlike traditional alcohol dependence medications, which often work by creating aversion or blocking euphoria after drinking, GLP-1 therapy works upstream — reducing the desire before it takes hold. This represents a meaningful shift in how we think about supporting recovery: not as punishment or restriction, but as recalibrating the brain's relationship with alcohol at a biological level.
The Journey
What to Expect
Every journey is paced to the individual. Here's how treatment typically unfolds — a measured, monitored process designed to move at a comfortable pace.
STEP 1
Initial Assessment
A clinician reviews your health history and drinking patterns through a confidential questionnaire, building a clear picture of your needs before anything begins.
STEP 2
Starting Low
Treatment begins at a deliberately low dose, closely monitored so your body can adjust gently and any early responses are observed with care.
STEP 3
Gradual Adjustment
Over the following weeks, your dose is titrated based on how you respond and tolerate it — adjusted slowly and only as needed, never rushed.
STEP 4
Ongoing Support
Regular check-ins track cravings and progress, combined with counselling or other support where appropriate — care that continues for the long term.
This timeline is illustrative. The exact pace and details of treatment are determined individually by a registered clinician following assessment. Individual experiences vary.